XOI


Also found in: Wikipedia.
AcronymDefinition
XOIExecutive Officer Inquiry (US Navy)
References in periodicals archive ?
Drugs known as xanthine oxidase inhibitors (XOIs) block the activity of an enzyme involved in purine metabolism, thus reducing uric acid levels.
Mandell said pegloticase (Krystexxa) via infusion can help patients who don't respond to an XOI but infusion reactions can occur (mainly in nonresponders), and it's extremely expensive (about $20,000 per month).
The aim of this study was to look for the experimental conditions for extraction leading to maximum production of XOI from Morinda elliptica leaves using an aqueous-methanol as extraction solution.
Therefore the search for new and safe XOI for the treatment of gout and various other diseases is urgently required.
danh lam thang canh rat xa xoi voi nhang gi cac em biet nen cac em khong
Metaphor Solutions and XO Interactive (XOI) have announced a reseller agreement for XOI to deploy Metaphor's speech IVR applications on XOI's hosting infrastructure.
"Cong la du' mui xoi, th[u.sup.dot]c banh, / Nhiem-nhat thay d[u.sup.dot][o.sup.dot]ng chi mui kim.
Nam thi muoi hoan nen chang cho Mot thang doi lan co cung khong Co dam an xoi, xoi lai hong Cam bang lam muon, muon khong cong Than nay vi biet duong nay nhi Tha truoc thoi danh o'vay xong Sharing a Husband One snug under a warm quilt, the other out in the cold The tate ot sharing a husband -- damn it all!
branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), and lesinurad, which is approved to be taken with a xanthine oxidase inhibitor (XOI) for the treatment of hyperuricemia associated with uncontrolled gout.
Lesinurad is currently approved under the brand name Zurampic by the FDA and needs to be administered in combination with a xanthine oxidase inhibitor (XOI) like allopurinol or febuxostat for treating hyperuricemia in gout patients who do not achieve the target serum uric acid (sUA) level when treated with a XOI alone.
Members voted 14-0 that the data in the four pivotal phase III trials submitted to the FDA contained enough evidence of a clinically meaningful beneficial effect of lesinurad in combination with a xanthine oxidase inhibitor (XOI) in the treatment of hyperuricemia associated with gout.